MedPath

Effect of omega 3 in Parkinson disease.

Phase 3
Conditions
parkinson.
Registration Number
IRCT20100123003140N21
Lead Sponsor
Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
44
Inclusion Criteria

Those who have Parkinson's diagnosis by a neurologist
Those aged 50-70
People who do not use aspirin or another anticoagulant, or statin

Exclusion Criteria

Unwillingness to cooperate
Patients who already took Omega-3 (6 months ago)
Patients who have depression or psychosis or have another inflammatory disease
Patients who are unable to take supplementation due to digestive problems or allergic reactions
Patients who smoke and drink alcohol

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Serum levels of IL-1B. Timepoint: The beginning and the end of the study. Method of measurement: ELISA KIT.;Serum levels of IL-6. Timepoint: The beginning and the end of the study. Method of measurement: ELISA KIT.;Serum levels of TNF-a. Timepoint: The beginning and the end of the study. Method of measurement: ELISA KIT.;Serum levels of IL-10. Timepoint: The beginning and the end of the study. Method of measurement: ELISA KIT.;Serum levels of TG. Timepoint: The beginning and the end of the study. Method of measurement: LBL KIT.;Serum levels of HDL. Timepoint: The beginning and the end of the study. Method of measurement: LBL KIT.;Serum levels of LDL. Timepoint: The beginning and the end of the study. Method of measurement: By the formula.
Secondary Outcome Measures
NameTimeMethod
Check for food. Timepoint: At first and during the study. Method of measurement: A 24-hour recall questionnaire and MNA questionnaire MNA.;Physical activity review. Timepoint: At the beginig of the study. Method of measurement: RAPA questionnaire.;Anthropometric Indicators. Timepoint: The beginning and the end of the study. Method of measurement: Impedance bi-electric system.;BMI. Timepoint: The beginning and the end of the study. Method of measurement: By the formula.;Serum Alb level. Timepoint: Beginning of study. Method of measurement: Enzymatic.
© Copyright 2025. All Rights Reserved by MedPath